Key Officials In Japanese MHW Reshuffle
Taking advantage of annual staff changes, Japan's Ministry of Health and Welfare has said that key senior executive changes will be made from from July 2, when they will be formally accepted by the Cabinet.
MHW Health Insurance Bureau head Nobuhara Okamitsu will become vice minister, directly under Minister Naoto Kan, succeeding Hiroshi Tada who retires. Mr Okamitsu will be succeeded at the HIB by Takehiko Yamaguchi, who will be replaced as head of the MHW secretariat by Jungoro Kondo.
Two senior executives who have been criticized for their part in the HIV scandal will leave. Health Service Bureau head Akihito Matsumara, a section manager in charge of blood products in 1985, retires on July 2 and has had a one-month pay cut of 10%. Also leaving is Pharmaceutical Affairs Bureau head Yasuta Araga, who, with 12 others, was disciplined with pay cuts and other measures at end-May.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze